MENU
PROK
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
ProKidney (PROK) Earnings Date & Reports
ProKidney Corp is a clinical-stage biotechnology company pioneering the development of a first-in-class, autologous cell therapy that is intended to preserve kidney function in patients with advance chronic kidney disease (CKD) and diabetes... Show more
A.I. Advisor
published Earnings
PROK is expected to report earnings to fall 13.33% to -12 cents per share on November 09
Q3'26
Est.
$-0.13
Q2'26
Missed
by $0.01
Q4'25
Beat
by $0.01
Q3'25
Beat
by $0.03
Q2'25
Beat
by $0.02
The last earnings report on August 10 showed earnings per share of -15 cents, missing the estimate of -14 cents. With 290.13K shares outstanding, the current market capitalization sits at 300.85M.
View a ticker or compare two or three
VS
VS
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
Interesting Articles
A.I. Advisor
published General Information
General Information
Industry Biotechnology
Industry
N/A
Address
2000 Frontis Plaza Boulevard
Phone
+1 336 999-7019
Employees
231
Web
https://www.prokidney.com